- Seasonal influenza activity remains low nationally.
- Influenza A(H1N1)pdm09 and A(H3N2) viruses are co-circulating, with varying distribution by region.
- Clinical laboratories reported that 0.7% of specimens tested were positive for influenza, with 88.5% being Influenza A and 11.5% being Influenza B.
- Public health laboratories reported that 96.9% of specimens tested were positive for Influenza A and 3.1% were positive for Influenza B.
- The percentage of outpatient visits for respiratory illness, including ILI, was 2.1%, which is below the national baseline of 3.0%.
- ILI activity varied by age group, with an increase in the 0-4 years age group and stability in other age groups.
- Geographic analysis showed minimal ILI activity in most jurisdictions, with one jurisdiction (Louisiana) experiencing moderate activity.
- Influenza-associated hospitalizations and pediatric deaths were not reported for the current season.
- CDC recommends annual influenza vaccination for everyone aged 6 months and older.
- Antiviral drugs are available for the treatment of flu illness.
- CDC performs genetic and antigenic characterization of circulating influenza viruses to monitor their similarity to reference viruses and assess their susceptibility to antiviral medications.
- NCHS mortality surveillance data indicated that 0.05% of deaths during Week 42 were due to influenza, which is below the epidemic threshold.
- Additional influenza surveillance information is available through various national and international organizations.